Sinphar Pharmaceutical Co Ltd (1734):企業の財務・戦略的SWOT分析

◆英語タイトル:Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0995
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sinphar Pharmaceutical Co Ltd (1734) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sinphar Pharmaceutical Co Ltd (Sinphar) is a healthcare company that carries out the development, manufacture and sale of pharmaceutical drugs, healthy foods and cosmetics. The company’s pharmaceutical product portfolio includes antifungal agents, anti-hypersensitive agents, cardiovascular agents, dermatologic agents, ophthalmic agents, skincare products, health supplements and others. It also has several products in pipeline addressing dementia, dry age-related macular degeneration, triple-negative breast cancer, pancreatic cancer, genital warts and others. Sinphar offers contract manufacturing services to pharmaceutical companies for the development of new products. It has presence in China, Taiwan, Canada and other countries. Sinphar is headquartered in Tungshan, Yilan, Taiwan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sinphar Pharmaceutical Co Ltd – Key Facts
Sinphar Pharmaceutical Co Ltd – Key Employees
Sinphar Pharmaceutical Co Ltd – Key Employee Biographies
Sinphar Pharmaceutical Co Ltd – Major Products and Services
Sinphar Pharmaceutical Co Ltd – History
Sinphar Pharmaceutical Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sinphar Pharmaceutical Co Ltd – Business Description
Sinphar Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Sinphar Pharmaceutical Co Ltd – Strengths
Sinphar Pharmaceutical Co Ltd – Weaknesses
Sinphar Pharmaceutical Co Ltd – Opportunities
Sinphar Pharmaceutical Co Ltd – Threats
Sinphar Pharmaceutical Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sinphar Pharmaceutical Co Ltd, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sinphar Pharmaceutical Co Ltd, Key Facts
Sinphar Pharmaceutical Co Ltd, Key Employees
Sinphar Pharmaceutical Co Ltd, Key Employee Biographies
Sinphar Pharmaceutical Co Ltd, Major Products and Services
Sinphar Pharmaceutical Co Ltd, History
Sinphar Pharmaceutical Co Ltd, Subsidiaries
Sinphar Pharmaceutical Co Ltd, Key Competitors
Sinphar Pharmaceutical Co Ltd, Ratios based on current share price
Sinphar Pharmaceutical Co Ltd, Annual Ratios
Sinphar Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
Sinphar Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
Sinphar Pharmaceutical Co Ltd, Interim Ratios
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sinphar Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Sinphar Pharmaceutical Co Ltd, Performance Chart (2014 - 2018)
Sinphar Pharmaceutical Co Ltd, Ratio Charts
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Sinphar Pharmaceutical Co Ltd (1734):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aspire Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aspire Health Inc (Aspire) is a healthcare company which operates a network of outpatient palliative care practices providing medical care for patients with relief from the symptoms, pain, and stress of a serious illness. Its service offerings include symptom and disease management, in-home …
  • Calgary Scientific Inc-医療機器分野:企業M&A・提携分析
    Summary Calgary Scientific Inc (Calgary Scientific) is a scientific software company that provides technology solutions for the medical industry. The company offers ResolutionMD, a diagnostic medical imaging software solution that acts as an enterprise image viewer for doctors to view patient images …
  • Laing O’Rourke Australia Pty Ltd:企業の戦略的SWOT分析
    Laing O'Rourke Australia Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • ConocoPhillips:企業の戦略・SWOT・財務情報
    ConocoPhillips - Strategy, SWOT and Corporate Finance Report Summary ConocoPhillips - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Harbin Electric Co Ltd (1133):企業の財務・戦略的SWOT分析
    Harbin Electric Co Ltd (1133) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Scynexis Inc (SCYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company provides pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis …
  • Companhia de Eletricidade do Estado da Bahia SA (CEEB5):企業の財務・戦略的SWOT分析
    Summary Companhia de Eletricidade do Estado da Bahia SA (COELBA) is a power distribution company that offers electricity services. The company's services include power supplying, electrical damage, shutdown consumer unit, load change, debts information, microgeneration connection and power minigener …
  • Societe Anonyme Belge de Constructions Aeronautiques:企業の戦略・SWOT・財務分析
    Societe Anonyme Belge de Constructions Aeronautiques - Strategy, SWOT and Corporate Finance Report Summary Societe Anonyme Belge de Constructions Aeronautiques - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • American Dental Partners Inc:企業の戦略的SWOT分析
    American Dental Partners Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • TPG Telecom Ltd (TPM):企業の財務・戦略的SWOT分析
    TPG Telecom Ltd (TPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Dynegy Inc:発電所・企業SWOT分析
    Dynegy Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Defense Commissary Agency:企業の戦略的SWOT分析
    Defense Commissary Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Factory Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Factory Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Factory Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Neon Therapeutics Inc (NTGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Neon Therapeutics Inc (Neon Therapeutics) is a clinical-stage immuno-oncology company that focuses on the development of neoantigen-based therapeutics for the treatment of cancer. The company pipeline product portfolio comprises NEO-PV-01, a personal neoantigen vaccine; NEO-PTC-01, a persona …
  • Saturn Oil & Gas Inc (SMI):石油・ガス:M&Aディール及び事業提携情報
    Summary Saturn Oil & Gas Inc (Saturn) formerly Saturn Minerals Inc, is a mineral exploration company that acquires, explores and develops oil and gas, potash and coal resources. The company’s oil and gas project is situated between the towns of Tisdale and Hudson Bay in Eastern Saskatchewan. It prov …
  • Petro Matad Ltd (MATD):企業の財務・戦略的SWOT分析
    Summary Petro Matad Ltd (Petro Matad) is an oil and gas company that develops and operates oil and gas exploration properties. The company’s upstream oil and gas exploration asset base includes Block IV, Block XX, and Block V. Its Block XX is located in the far eastern part of Mongolia producing oil …
  • Laureate Education, Inc.:企業のM&A・事業提携・投資動向
    Laureate Education, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Laureate Education, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Mulberry Group PLC (MUL):企業の財務・戦略的SWOT分析
    Mulberry Group PLC (MUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Invectys SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Invectys SA (Invectys) is a biopharmaceutical company that develops immunotherapy to treat cancer. The company provides product pipeline such as INVAC-1, a DNA vaccine targeting Telomerase; Universal Cancer Peptide vaccine UCPVax. It offers products such as a human telomerase peptide-based v …
  • Bioactive Bone Substitutes Ltd:製品パイプライン分析
    Summary Bioactive Bone Substitutes Ltd (BBS) is a manufacturer of biologically active medical device implants for orthopedic surgery. The company offers technology platforms, artebone, research and development, and patents. Its artebone is made up of an animal source of bone material used for bone r …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆